会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 45. 发明申请
    • A METHOD FOR HEALTH MONITORING
    • 一种健康监测方法
    • WO2007060246A2
    • 2007-05-31
    • PCT/EP2006/068978
    • 2006-11-28
    • NAKOSTECH SARLPOULETTY, PhilippeCOHEN, Daniel
    • POULETTY, PhilippeCOHEN, Daniel
    • G06T7/0012G06T2207/30004
    • This invention relates to methods for monitoring the anatomy of an individual, which methods comprise the steps of : (i) subjecting a healthy or asymptomatic individual to non-invasive analysis techniques, such as imaging or acoustic techniques, to obtain images or data on determined cells, tissue(s) or organs, at different time points over a period of more than one month, preferably over years; (ii) collecting the images or data in a database; (iii) comparing the images or data to the images or data previously acquired for the same individual, in essentially the same conditions; wherein said comparison of images or data obtained at different time points allows definition of non-pathological baseline anatomy for this individual.
    • 本发明涉及用于监测个体的解剖结构的方法,所述方法包括以下步骤:(i)使健康或无症状的个体经历非侵入性分析技术,诸如成像或声学技术 以在超过一个月的时间,优选超过几年的时间内在不同时间点获得确定的细胞,组织或器官上的图像或数据; (ii)收集数据库中的图像或数据; (iii)在基本上相同的条件下将图像或数据与之前针对同一个体获得的图像或数据进行比较; 其中所述在不同时间点获得的图像或数据的比较允许定义该个体的非病理性基线解剖结构。
    • 48. 发明申请
    • NEW DIAGNOSTIC TOOLS FOR CHARCOT-MARIE-TOOTH DISEASE
    • 用于CHARCOT-MARIE-TOOTH疾病的新诊断工具
    • WO2017001360A2
    • 2017-01-05
    • PCT/EP2016/064918
    • 2016-06-28
    • PHARNEXT
    • COHEN, DanielCHUMAKOV, IlyaNABIROCHKIN, Serguei
    • G01N33/68G01N33/92
    • G01N33/6896G01N33/92G01N2800/52
    • The present invention relates in particular to methods of detecting predisposition to or diagnosis and/or prognosis of Charcot-Marie-Tooth (CMT) and related disorders. More specifically, the invention relates to development, validation and application of new biomarkers, which can be used for detecting the presence or risk of CMT disease and related disorders. In particular, the present invention relates to metabolite, lipid, carbohydrate and proteinaceous biomarkers that can be measured in biological body fluids and easily available extracts of biopsies, which can be used to aid in the detection, prediction of drug treatment and follow up of this treatment of neurodegenerative disorders, including CMT disease. The present invention also relates to methods for identification of CMT disease sub-types, assessing the responsiveness to the treatments and the efficacy of treatments in subjects having CMT or a related disorder.
    • 本发明特别涉及检测Charcot-Marie-Tooth(CMT)和相关病症的倾向或诊断和/或预后的方法。 更具体地说,本发明涉及新的生物标记的开发,验证和应用,其可用于检测CMT疾病和相关病症的存在或风险。 具体而言,本发明涉及可在生物体液中测量的代谢物,脂质,碳水化合物和蛋白质类生物标志物以及活检样品的容易获得的提取物,其可用于帮助检测,预测药物治疗并跟踪此 治疗神经退行性疾病,包括CMT疾病。 本发明还涉及用于鉴定CMT疾病亚型的方法,评估对具有CMT或相关病症的受试者的治疗的应答​​性和治疗效果。